×
About 10,566 results

Pfizer Exporting US-Made COVID-19 Vaccines to Mexico, Canada
https://www.medscape.com/viewarticle/950358

May 2nd, 2021 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. Pfizer began exporting COVID-19 vaccines to Mexico last week that were made in its U.S. plant in Kalamazoo, Michigan, according to Reuters. Last week's shipment marks the first time that Pfizer has delivered doses abroad from U.S. facilities after a Trump administration restriction on dose expor...

Norway Offers MRNA COVID-19 Vaccines to Those Who First Got AstraZeneca's
https://www.medscape.com/viewarticle/949841

Apr 25th, 2021 - OSLO (Reuters) — Norway will offer those who have received a dose of the AstraZeneca vaccine against COVID-19 to take an injection from an mRNA vaccine as their second dose, the health ministry said on Friday. Norway on March 11 suspended the rollout of the AstraZeneca vaccine after a small number of younger people were hospitalised for a combination of blood clots, bleeding and a low count of ...

Biden Offers Tax Credits for COVID-19 Vaccine Paid Time Off
https://www.medscape.com/viewarticle/949801

Apr 21st, 2021 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. President Joe Biden announced tax credits for some businesses to give paid time off for their employees to get COVID-19 vaccines, according to Reuters. Businesses will be reimbursed for the cost of giving workers up to 80 hours in paid time off to get their shots and recover from side effects. "...

Low Risk of Delayed Brain Bleed After Blunt Head Trauma in Older People on DOAC Therapy
https://www.medscape.com/viewarticle/949377

Apr 15th, 2021 - NEW YORK (Reuters Health) - There is a low risk of delayed intracranial hemorrhage (ICH) in older patients on direct oral anticoagulant (DOAC) therapy who fall and hit their head, according to a new study. This finding calls into question the need to extended observation in the hospital or repeat head CT scan after an initial negative CT scan, the researchers say. To evaluate the risk of delaye...

Eli Lilly's Arthritis Drug Fails to Prevent Mechanical Ventilation in COVID-19 Patients
https://www.medscape.com/viewarticle/948951

Apr 8th, 2021 - (Reuters) - Eli Lilly and Co and Incyte Corp said their rheumatoid arthritis drug baricitinib did not meet the main goal of preventing progression to mechanical ventilation in hospitalized COVID-19 patients under a late-stage study. Patients receiving baricitinib were 2.7% less likely than those receiving standard of care to progress to ventilation, which was not statistically significant, the ...

Brolucizumab Appears to Have 'Drying' Effect in Neovascular AMD, Short Study Finds
https://www.medscape.com/viewarticle/947425

Mar 15th, 2021 - NEW YORK (Reuters Health) - Patients with neovascular age-related macular degeneration (nAMD) who receive intravitreous injection (IVI) with brolucizumab have stable visual acuity over the short term and show a drop in central-subfield thickness, according to a new case series. To examine early experience with the drug, an anti-vascular endothelial growth factor (VEGF) approved by the U.S. Food...

SARS-CoV-2 Surface Contamination in Cancer Centers 'Negligible'
https://www.medscape.com/viewarticle/946773

Mar 3rd, 2021 - NEW YORK (Reuters Health) - With strict infection-control protocols, surfaces in outpatient and inpatient hematology/oncology settings are unlikely to be contaminated with SARS-CoV-2, new research indicates. Studies have shown that contaminated surfaces may contain viable virus for up to 72 hours in laboratory settings. The potential risk of becoming infected with SARS-CoV-2 has dissuaded some ...

EU Drugs Watchdog Partners With Regulators on COVID-19 Vaccines, Drugs
https://www.medscape.com/viewarticle/945269

Feb 4th, 2021 - (Reuters) - Europe's drugs regulator said on Thursday it had started sharing COVID-19 vaccine and treatment expertise with its counterparts in several countries, aiming to speed up regulatory processes around the world. The pilot aims to speed up development and assessment of COVID-19 medicines and make them available to the public faster, the European Medicines Agency said, adding that the col...

Oxford Finds COVID-19 Shot 76% Effective for 3 Months After Single Dose
https://www.medscape.com/viewarticle/945132

Feb 2nd, 2021 - LONDON (Reuters) - Oxford University and AstraZeneca's COVID-19 vaccine showed in a study it had 76% efficacy against symptomatic infection for three months after a single dose, which increased if the second shot is delayed, backing Britain's vaccine rollout policy. The findings of the paper, published ahead of peer-review by Preprints with The Lancet, supported Britain's decision to extend the...

Russia's COVID-19 Vaccine 91.6% Effective, Studies Show
https://www.medscape.com/viewarticle/945141

Feb 1st, 2021 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. Phase III clinical trials show Russia's Sputnik V coronavirus vaccine is 91. 6% effective in fighting COVID-19, according to research published in The Lancet

After 10 Months of Quarantine, Chronically Ill Young German Jumps Vaccine Queue
https://www.medscape.com/viewarticle/944541

Jan 24th, 2021 - NIEDERBREITBACH, Germany (Reuters) - Since the outbreak of the coronavirus pandemic, chronically ill 30-year-old Benni Over has lived in strict domestic quarantine in the German resort town of Niederbreitbach with his parents, who look after him around the clock. As a result of his illness, the muscle-wasting disorder Duchenne Muscular Dystrophy, Over can move only his fingers and has to receiv...

Moderna CEO: Vaccine Will Likely Work for 'a Couple of Years'
https://www.medscape.com/viewarticle/943736

Jan 6th, 2021 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. The Moderna vaccine ― one of two vaccines now being distributed in the United States ― will "potentially" provide protection against COVID-19 for several years, the biotech company's CEO said, according to Reuters.

Feds to Start Using Pharmacies to Ramp Up Administration of COVID Vaccines
https://www.medscape.com/viewarticle/943677

Jan 5th, 2021 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. The federal government is turning to private pharmacies to administer COVID-19 vaccines, in an effort to speed up the number of Americans being inoculated against the disease. A Centers for Disease Control and Prevention (CDC) vaccine tracker reports that at least 5.3 million doses have been adm...

British Family Doctors Criticise Change of Plan on Vaccine Boosters
https://www.medscape.com/viewarticle/943452

Jan 1st, 2021 - LONDON (Reuters) - British doctors have said a government decision to delay giving a coronavirus vaccine booster shot to vulnerable patients who have already had a first dose will be distressing and disruptive, their trade union said on Thursday. The government said on Wednesday it wanted to give a first dose to as many people as possible before starting to administer boosters at 12 weeks, in a...

2.1 Million COVID Vaccine Doses Given in U.S.
https://www.medscape.com/viewarticle/943312

Dec 28th, 2020 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. The U. S

South Korea to Boost Testing as Coronavirus Surge Threatens 'Medical Collapse'
https://www.medscape.com/viewarticle/942104

Dec 7th, 2020 - SEOUL (Reuters) - South Korean President Moon Jae-in called on Monday for expanded coronavirus testing and more thorough tracing as the country struggles to control its latest and largest wave of infections. The Korea Disease Control and Prevention Agency reported 615 new coronavirus cases as of midnight Sunday, capping a month of triple-digit daily increases that have led to 8,311 confirmed pa...

33 Million in California Under Stay-at-Home Order
https://www.medscape.com/viewarticle/942180

Dec 7th, 2020 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. More than 33 million Californians are now under a shelter-at-home order that could extend through Christmas.

Hyperbaric Oxygen Therapy Reverses Biological Signs of Aging
https://www.staging.medscape.com/viewarticle/941282

Nov 19th, 2020 - NEW YORK (Reuters Health) - Two biological hallmarks of aging - telomere shortening and accumulation of senescent cells - can apparently be reversed with hyperbaric oxygen therapy (HBOT), according to a new study from Israel. "Following 20 years of research, we are able to demonstrate that the aging process can be reversed at the cellular (telomere) and brain-tissue structural and functional le...

Hyperbaric Oxygen Therapy Reverses Biological Signs of Aging
https://www.medscape.com/viewarticle/941282

Nov 19th, 2020 - NEW YORK (Reuters Health) - Two biological hallmarks of aging - telomere shortening and accumulation of senescent cells - can apparently be reversed with hyperbaric oxygen therapy (HBOT), according to a new study from Israel. "Following 20 years of research, we are able to demonstrate that the aging process can be reversed at the cellular (telomere) and brain-tissue structural and functional le...

COVID-19 Circulated in Italy Earlier Than Thought
https://www.medscape.com/viewarticle/941126

Nov 16th, 2020 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. The novel coronavirus was circulating in Italy as early as September 2019, according to a new study by the country's national cancer institute, which looked for the virus in blood samples in Milan.